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GRONEVELD, D., P. H. M. BALM AND S. E. W ENDELAAR BONGA. Biphasic effect of MCH on a-MSH release from the 
tilapia (Oreochromis mossambicus) pituitary'. PEPTIDES 16(5) 945-949, 1995.— The effect of melanin-concentrating hormone 
(MCH) on the release of a-melanocyte stimulating hormone (a-MSH) from the tilapia pituitary gland was studied in vitro. In a 
superfusion set up, 10 nM to 1 pM synthetic salmon MCH caused a concentration-dependent inhibition of a-MSH release from 
tilapia neurointermediate lobes (NILs). Immunoneutralization of MCH in tilapia NILs further indicated that endogenous MCH has 
an inhibitory effect on the melanotropes. The release of monoacetylated a-MSH release was more strongly inhibited by MCH 
than that of des-, and diacetylated a-MSH, indicating that MCH modulates the secretory signal of the melanotropes in a quantitative 
and qualitative manner. A high concentration of MCH (10 pM) substantially increased the release of a-MSH. Further evidence in 
support of a stimulatory action of high concentrations of MCH was provided by the observation that the MCH analogue MCH(2- 
17) at 10 and 35 pM enhanced a-MSH release as well. Therefore, we conclude that the response of pituitary melanotropes to 
MCH is biphasic, as was reported previously for the effects of MCH on other targets in fish and mammals. Under physiological 
conditions the inhibitory action of MCH on fish melanotropes most likely dominates.
Melanin-concentrating hormone (MCH) a-Melanocyte-stimulating hormone (a-MSH) Teleost Pituitary
MANY lower vertebrates alter the color of their skin in response 
to variations in background coloration. Background adaptation is 
of paramount importance to these animals for survival. The reg­
ulation of background adaptation represents an attractive model 
for the analysis of the interactions between peptidergic neuroen­
docrine factors. In most species a-melanocyte-stimulating hor­
mone (a-MSH), dominates the hormonal control of pigment mi­
gration in response to changes in background coloration. a-MSH 
is produced in the melanotropes of the pars intermedia of most 
vertebrates, and induces pigment dispersion ( 1). In teleosts a neu­
rohormone, melanin-concentrating hormone (MCH), antagonizes 
a-MSH in this respect (5). As in other teleosts (4), in tilapia 
(Oreochromis mossambicus) MCH is synthesized in the hypo­
thalamus and transported to the pituitary pars nervosa (18). Also 
in higher vertebrates, MCH is produced in the hypothalamus (4), 
and it plays a role in the stress response, in osmoregulation, and 
in lactation (2). In teleosts the MCH system appeared to be re­
sponsive to stress and ionic challenges as well (4,6,15-17), in 
addition to its function in the regulation of skin color.
There are indications that MCH may affect background 
adaptation at the level of the pituitary by inhibiting a-MSH re­
lease from the pars intermedia. Firstly, MCH nerve terminals are 
located in the vicinity of pars intermedia cells (10,29). Further­
more, it has been reported that trout injected with MCH had 
decreased plasma a-MSH levels (7), and immunoabsorbance of 
endogenous MCH in trout and eel pituitary tissue enhanced the 
release of a-MSH in vitro (9).
At present, little is known on the sensitivity of pituitary me­
lanotropes to MCH, and on species differences for the effect of 
MCH on melanotropes. In the teleost skin, MCH induces aggre­
gation of melanin at concentrations that occur in the blood (3,4), 
whereas administration of high concentrations of MCH to mel- 
anophores induces pigment dispersion. The latter has been ex­
plained by binding of MCH to a-MSH receptors on the mela- 
nophores (12,19). The MCH concentration-response curve of 
MCH on auditory gating in rats is also biphasic (27). This raises 
the question whether the concentration-response relationship of 
MCH on a-MSH release is biphasic as well.
Three forms of a-MSH are known: des-, mono-, and diacetylated 
a-MSH. In tilapia, all three a-MSH forms are released from the 
neurointermediate lobe (NIL) (25). Acetylation of a-MSH is of 
functional significance, because the isoforms of a-MSH have dif­
ferent melanotropic and corticotropic potencies in fish (22,24). 
Monoacetylated and diacetylated a-MSH are most effective on pig­
ment dispersion in trout (22), whereas in particular diacetylated a- 
MSH has corticotropic activity in tilapia (8,24).
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The purpose of the present study was to gain more insight 
into the action of MCH at the pituitary level. We therefore quan­
titatively and qualitatively analyzed the effects of MCH and 
MCH(2-17), a MCH analogue lacking the AMerminal amino 
acid, which was helpful in elucidating the mechanisms of action 
of MCH on the teleost skin (11,26), on the release of a-MSH in 
vitro from the tilapia pituitary gland.
METHOD
Animals
Male and female tilapia (Oreochromis mossambicus), average 
weight 80 g, were bred in the aquarium facility of the Dept, of 
Animal Physiology of the University of Nijmegen. They were 
kept in fresh water at 28°C and were fed a commercial dried fish 
food (Tetramin). The fish were kept in glass aquaria, illuminated 
by overhead TL tubes, with a day-night rhythm of 12 h light 
and 12 h darkness. Immediately after removal from the tank, the 
animals were sacrificed by spinal transection and pituitary glands 
were dissected from the brain.
Superfusion of Neurointermediate Lobe Tissue
One or two freshly dissected pituitaries or NILs were placed 
on a nylon gauze in a 10-//1 superfusion chamber. A multichannel 
peristaltic pump (Whatson Marlow) was used to pump carbogen- 
aerated incubation medium (IM) {142 mM NaCl, 2 mM KC1, 2 
mM CaCl2, 15 mM HEPES (pH 7.38), 0.3 mg/ml bovine serum 
albumin (Sigma), 2.5 mg/ml glucose] through each chamber at a 
rate of 30 /d/min. The superfusion chambers as well as the IM 
were thermostat controlled at 28°C. The effluent from each cham­
ber was collected in fractions over varying periods with an Isco 
(Retriever II model) fraction collector. During at least 3 h super­
fusion fractions were collected before switching to pulse medium 
containing MCH or MCH(2-17) (both synthesized by Dr. T.O. 
Matsunaga at the lab of Dr. V. J. Hruby and kindly provided by 
Dr. M. E. Hadley, Tuscon, AZ) (32), for a 25-30-min period. 
After the pulse the superfusion was continued with IM. The col­
lected fractions were stored immediately at -20°C until a-MSH 
radioimmunoassay.
Immunoneutralization of MCH From Tilapia NILs
NILs from tilapia kept in dark glass aquaria were dissected 
and individually preincubated in 100 /¿I IM, containing 5 mg/ml
(w/v) glucose, during 1 h at 28°C. Subsequently, the NILs were 
transferred into 30 //I IM containing either 0.1% (v/v) MCH an­
tiserum (a kind gift of Dr. B.I. Baker and Dr. H. Kawauchi) (28) 
or 0.1% (v/v) normal rabbit serum. The vials were aerated with 
carbogen, sealed, and shaken gently at 28°C for a 15-h incubation 
period. After this static incubation, media were collected and 
stored at -20°C until a-MSH radioimmunoassay; subsequently, 
the NILs were superfused as described above.
Reversed-Phase HPLC Analysis
To determine the effect of MCH on the profile of the secretory 
signal, superfusate was submitted to HPLC analysis. Different 
forms of a-MSH were separated on a Spherisorb 10 ODS column 
(Bisschof) as described previously (25). In short, the primary 
solvent was buffer B (0.5 M formic acid, 0.14 M pyridine, pH 
3.0) and elution was accomplished with a gradient of 1-propanol 
at a flow rate of 2 ml/min. Fractions of 0.6 ml were collected. 
The fractions were dried in a Speedvac concentrator (Savant), 
diluted into 0.05 N HC1, 50% methanol, and submitted to a-MSH 
radioimmunoassay.
a-MSH Radioimmunoassay
The a-MSH radioimmunoassay (RIA) with L9 a-MSH anti­
serum has been described previously (24). The antiserum is 
equally sensitive to des-, mono- and diacetyl a-MSH. Cross-reac­
tivity of the a-MSH antiserum with MCH [preliminary results 
have been reported by De Koning et al. (13)] and MCH(2-17) 
was assessed (see the Results section).
Processing of Data and Statistics
The results of the superfusions are either expressed as pg a- 
MSH per min per NIL, or as a percentage of the basal release 
(=100%). Basal release was defined as the average a-MSH re­
lease in 20-30 min prior to addition of secretagogue, and basal 
release values ranged from 30 to 200 pg/min/NIL. For the con- 
centration-response relationships of MCH- or MCH(2-17)-in- 
duced effects, values for maximal inhibition or stimulation of a- 
MSH release during the secretagogue pulse were expressed as a 
percentage of the prepulse values. Correction of a-MSH values 
for cross-reactivity after a 10-^M MCH pulse was performed as 
follows: proceeding from 0.0032% cross-reactivity (see the Re-
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FIG. 1. Inhibitory' (A) and stimulator)' (B) effects of MCH on a-MSH release from tilapia NILs during in vitro 
superfusion expressed as percentage of basal release (=100%). (A) 250 nM MCH, n = 12; (B) 10 /.lM MCH, n = 9. 
The lime of addition of secretagogue after at least 220 min of superfusion is designated /0. (C) Concentration-response 
relationship of MCH induced effects on a-MSH release. Basal release in this presentation is designated 0%. Numbers 
of incubations are given in parentheses for each concentration tested. *p <  0.05, ***p <  0.001.
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FIG. 2. Cross-reactivity of MCH with a-MSH antiserum. Concentration 
series of MCH ( ♦ ) and MCH(2- 17) (▲) in 50 p\ incubation medium 
were tested for cross-reactivity in a-MSH radioimmunoassay. B/B0 is 
compared with the a-MSH standard curve ( • ) .  Sample size 3 or 4. SEMs 
not shown fall within the area of the symbol. EDM, a-MSH = 1.8 nM, 
EDso MCH = 57 pM. MCH(2-17) did not cross-react.
suits section) we calculated that 10 pM MCH in a 75 p\ RIA 
sample is equivalent to 40 pg immunoreactive a-MSH. This 
value was subtracted from the RIA data of pulse fractions. EC50 
was estimated as described previously (23). Results are presented 
as means + , —, or ± SEM. For statistical analysis data were log 
transformed where appropriate. For the concentration-response 
relationships statistical analyses were performed using the paired 
Student’s Mest. For each concentration, the maximum value dur­
ing the pulse of each incubation was tested against its own control 
value of basal release. In other cases the unpaired Student’s t- 
test was used. To test parallelism of dilution curves the computer 
program PHARM/PCS-version 4.1 (30) was used.
RESULTS
Quantitative Effects of MCH on a-MSH Release
At concentrations below 1 f.iM, MCH caused a concentration- 
dependent inhibition of a-MSH release during in vitro superfu­
sion of tilapia NILs [Fig. 1(A,C)], and at 10 pM a-MSH release 
was stimulated [Fig. 1(B)]. The effect of MCH on the a-MSH 
release lasted for the duration of the pulse; after the pulse a-MSH 
release did restore to basal levels. The MCH concentration in­
ducing 50% of maximum inhibition of a-MSH release (EC50), 
using the data points up to and including 250 nM, was estimated 
to be 19 nM with a maximum inhibition of 42%. At 10 pM MCH 
the a-MSH release was stimulated with a maximum stimulation 
of 96 ± 17% (p < 0.001) [Fig. 1(C)]. Taking into account the 
slight cross-reactivity of MCH with the a-MSH antiserum 
(0.0032%) (Fig. 2), this percentage decreased marginally to 87 
± 22% (p < 0.001 compared with basal release). However, be­
cause the dilution curve for MCH only approximately paralleled 
the a-MSH dilution curve in the a-MSH radioimmunoassay (Fig. 
2; the slope of log transformed curves was significantly different, 
p < 0.01) an additional control was performed. To mimic pulse 
conditions, MCH was added to prepulse superfusates to a final 
concentration of 10 pM. This yielded a nonsignificant increase 
(p = 0.88) of immunoreactive a-MSH of 2 ± 10 pg (and 16 ± 
16%; n = 6) compared with untreated prepulse fractions. During 
the 10 pM MCH pulse the increase of immunoreactive a-MSH 
was 108 ± 33 pg (95 ± 28%; n = 5), which was significantly 
higher (p < 0.01) than the increase measured when MCH was 
added afterwards to superfusates. MCH(2-17), a MCH analogue
that, in contrast to MCH, did not cross-react with the a-MSH 
antiserum (Fig. 2), induced a significant stimulation of the a- 
MSH release at concentrations of 10 and 35 pM (Fig. 3). The 
stimulation of a-MSH release by 10 pM MCH(2-17) was com­
parable with that evoked by 10 pM MCH.
Effect of Endogenous MCH on a-MSH Secretion
After incubation of tilapia NILs with 0.1% MCH antiserum, 
to immunoneutralize endogenous MCH, a-MSH release signifi­
cantly increased compared with NILs incubated in medium con­
taining normal rabbit serum [Fig. 4(A)]. After 15 h of static in­
cubation, the antiserum was washed out by superfusion of the 
NILs with fresh incubation medium. During this superfusion the 
a-MSH release of the NILs incubated with the MCH antiserum 
returned to control levels within 2 h [Fig. 4(B)].
Effects of MCH on the Release of a-MSH Isoforms
To study the qualitative effect of MCH on a-MSH release, 
the isoforms of a-MSH released before and during pulses with 
100 and 250 nM MCH were analyzed by HPLC. Des-, mono-, 
and diacetylated a-MSH were released during MCH pulses as 
well as under control conditions (Fig. 5). During the 100 and 250 
nM MCH pulses the amount of monoacetylated a-MSH de­
creased relatively more than the amounts of des- and diacetylated 
a-MSH, when compared to control. Taking the area under the 
curve of diacetylated a-MSH (di), monoacetylated a-MSH 
(mono), and desacetylated a-MSH (des), we calculated di/mono 
and des/mono ratios of 0.45 and 0.38 for control, 0.73 and 0.50 
during a 100 nM MCH pulse, and 0.95 and 0.61 during a 250 
nM MCH pulse, respectively. The highest increase of the ratios 
was found at the concentration (250 nM) where the overall in­
hibitory effect was the strongest (Figs. 1 and 5).
D ISCU SSIO N
The present results demonstrate that the MCH concentration- 
response curve for a-MSH release from the tilapia NIL is bi- 
phasic. At concentrations below 1 pM, synthetic MCH caused a 
concentration-dependent inhibition of a-MSH release. Concen-
l 10
M CH j.17 (i iM)
35
FIG. 3. Stimulatory effect of MCH(2-17) on a-MSH release during in 
vitro superfusion. Concentration-response relationship is given for the 
effect of high concentrations of MCH(2-17) on a-MSH release. Num­
bers of incubations are given in parentheses. **p <  0.01, ***p < 0.001.
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FIG. 4. Effect of in vitro immunoneutralization of endogenously released 
MCH on a-MSH release from tilapia NILs. (A) a-MSH release of NILs 
incubated during 15 h with 0.1% MCH antiserum (anti-MCH; n = 4) vs. 
NILs incubated with normal rabbit serum as controls (C; n = 4). (B) a- 
MSH release during subsequent superfusion with normal incubation me­
dium of MCH antiserum-treated NILs ( • )  and controls (O). *p <  0.05.
trations above 1 yM of MCH stimulated a-MSH release. These 
results strongly resemble the autoantagonism phenomenon de­
scribed for the action of MCH on pigment cells in the skin of 
tropical eel (Synbranchus marmoratus) in vitro (12) and the bi- 
phasic concentration-response curve of the effect of MCH in 
auditory gating of rats (27).
Significant inhibition of a-MSH release from tilapia NILs oc­
curred from 10 to 250 nM MCH. In trout, MCH tested at a single 
dose of 100 nM did not inhibit a-MSH release in vitro (9). The 
difference with tilapia could be due to other incubation condi­
tions or to species differences in sensitivity of teleost melanotro- 
pes to MCH. An attractive hypothesis is that in trout 100 nM 
MCH reflects the turning point in the concentration-response 
curve. Tilapia melanotropes appeared to be less sensitive to MCH 
than tilapia scale melanophores: the EC50 of the effect of MCH 
on a-MSH release was 19 nM (this study), whereas the EC50 on 
pigment migration was 1 nM (20). We reason that the lower 
sensitivity of melanotropes to MCH reflects the mode of MCH 
targeting, which is neuroendocrine in the pituitary and in the 
classical sense endocrine for the skin. Pituitary melanotropes are 
in close contact with the MCH-containing neurons of the neu­
rohypophysis of tilapia (personal observation) and other teleosts 
(10,29), and MCH is endogenously released [(9), this study], 
whereas the effect of MCH on melanophores is exerted by rela­
tively low circulating MCH levels (14,21). The difference in sen­
sitivity of the tissues cannot be attributed to differences in the 
peptide sequences of synthetic salmon MCH and tilapia MCH, 
because we previously demonstrated that the sequences of both 
peptides are identical (18). The sensitivity of tilapia melanotropes 
to MCH is comparable with the sensitivity to dopamine, another 
potent inhibitor of a-MSH release in tilapia [EC5„, 10 nM\ Dr. 
A. E. Lamers personal communication; see also (25)]. However, 
MCH modulates the secretory output of the melanotropes not 
only quantitatively but also qualitatively by selectively decreas­
ing the release of monoacetylated a-MSH. In this respect MCH 
differs from dopamine, which indiscriminately inhibited the re­
lease of mono- and diacetylated a-MSH from tilapia NILs (25). 
The different mode of action of these two inhibitors might en­
hance the flexibility of the fish to respond to environmental chal­
lenges. Tilapia melanotropes are more sensitive to MCH than to 
thyrotropin-releasing hormone (TRH), a stimulator of a-MSH
release (EC50, 200 nM) (23). However, with respect to the effect 
on differential a-MSH release MCH resembles TRH, which also 
enhances the di/mono ratio of released a-MSH (25).
Immunoneutralization of MCH in NILs in vitro showed that 
in tilapia endogenous MCH inhibits a-MSH release from the 
melanotropes and that this inhibitory effect persists in vitro as 
long as 18 h, because after washout of the MCH antiserum a- 
MSH release restored to the low control levels. The inhibitory 
effect of MCH on tilapia melanotropes is in line with observa­
tions in trout and eel, that immunoabsorbance of endogenously 
released MCH enhanced the ratio of released over stored amounts 
of a-MSH (9). These findings indicate that under physiological 
conditions the effect of MCH on a-MSH is inhibitory.
High concentrations of MCH (10 /¿A/) and MCH(2-17) (10 
and 35 yM) significantly increased a-MSH release. The physi­
ological importance of this stimulation of a-MSH release is as 
yet unclear. It is doubtful whether concentrations up to 10 yM 
MCH, which are very high compared with MCH plasma values 
of trout (10 to 300 pA/) (14-16,21), occur in the teleost pituitary. 
However, it cannot be excluded that at the MCH nerve terminals 
in the vicinity of the melanotropes MCH occasionally reach mi­
cromolar concentrations. We demonstrated that the stimulation 
of a-MSH release by MCH could not be attributed to the slight 
cross-reactivity of MCH with the antibody used in the a-MSH 
RIA. The occurrence of this cross-reactivity supports the notion 
that the tertiary structures of a-MSH and MCH are related (11). 
Apparently, this structural similarity is lost when the N-terminal 
amino acid (Asp) of MCH is removed, because MCH(2- 17) ap­
peared not to cross-react with the a-MSH antibody (this study) 
and MCH(2-17) exhibited almost no a-MSH-like activity on 
skin melanophores (11,26). The stimulatory effect of MCH on 
the a-MSH release most probably is transduced by a mechanism 
different from that of the skin melanophores, because the effect 
of MCH(2- 17) on a-MSH release from tilapia NILs was similar 
to that of MCH. Possibly, two MCH receptor subtypes, an inhib­
itory and a stimulatory one, occur in the teleost pituitary. How­
ever, we cannot exclude that MCH, at a high concentration, binds 
to receptors for other a-MSH release stimulating agents, such as 
TRH or CRH (25,31), although no structural similarity with these 
peptides has been described.
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FIG. 5. HPLC immunogram of a-MSH in pooled NIL superfusion frac­
tions with or without MCH pulse. (A) Control, (B) 100 nM MCH, max­
imum inhibition of total a-MSH release in superfusion was 35 ± 7% (// 
= 8); (C) 250 nM MCH, maximum inhibition of total a-MSH was 47 ± 
6% (n = 4). Peak identification was based on Lamers et al. (25); des = 
desacetylated a-MSH, mono = monoacetylated a-MSH, di = diacety­
lated a-MSH.
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The finding that MCH interacts with the a-MSH cell not only 
has implications for our understanding of the roles of both cell 
types in background adaptation, but probably also for their func­
tions in the response to stressors. In tilapia, both cell types are 
responsive to acidification as a stressor ( 17,24), and in trout MCH 
secretion and biosynthesis are affected during injection and dis­
turbance stress (6,15).
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